Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins Journal Article


Authors: Gong, Y.; Zack, T. I.; Morris, L. G. T.; Lin, K.; Hukkelhoven, E.; Raheja, R.; Tan, I. L.; Turcan, S.; Veeriah, S.; Meng, S.; Viale, A.; Schumacher, S. E.; Palmedo, P.; Beroukhim, R.; Chan, T. A.
Article Title: Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
Abstract: Coordinate control of different classes of cyclins is fundamentally important for cell cycle regulation and tumor suppression, yet the underlying mechanisms are incompletely understood. Here we show that the PARK2 tumor suppressor mediates this coordination. The PARK2 E3 ubiquitin ligase coordinately controls the stability of both cyclin D and cyclin E. Analysis of approximately 5,000 tumor genomes shows that PARK2 is a very frequently deleted gene in human cancer and uncovers a striking pattern of mutual exclusivity between PARK2 deletion and amplification of CCND1, CCNE1 or CDK4-implicating these genes in a common pathway. Inactivation of PARK2 results in the accumulation of cyclin D and acceleration of cell cycle progression. Furthermore, PARK2 is a component of a new class of cullin-RING-containing ubiquitin ligases targeting both cyclin D and cyclin E for degradation. Thus, PARK2 regulates cyclin-CDK complexes, as does the CDK inhibitor p16, but acts as a master regulator of the stability of G1/S cyclins. © 2014 Nature America, Inc.
Keywords: gene deletion; genetic analysis; cell cycle progression; enzyme regulation; gene inactivation; tumor gene; cyclin e; cyclin d; regulator gene; g1 phase cell cycle checkpoint; human; priority journal; article; park2 gene
Journal Title: Nature Genetics
Volume: 46
Issue: 6
ISSN: 1061-4036
Publisher: Nature Publishing Group  
Date Published: 2014-06-01
Start Page: 588
End Page: 594
Language: English
DOI: 10.1038/ng.2981
PROVIDER: scopus
PUBMED: 24793136
PMCID: PMC4251771
DOI/URL:
Notes: Nat. Genet. -- Cited By (since 1996):1 -- Export Date: 8 July 2014 -- CODEN: NGENE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Timothy Chan
    317 Chan
  2. Luc Morris
    281 Morris
  3. Agnes Viale
    245 Viale
  4. Yongxing Gong
    10 Gong
  5. Sevin Turcan
    25 Turcan
  6. Shasha Meng
    4 Meng